Journal Information
Statistics
Follow this link to access the full text of the article
Original Article
Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Aerobic Capacity in Children With Cystic Fibrosis Aged 6–11 Years: Actual Observations and Clinical Perspectives
Margarita Pérez-Ruiza,1, Mats te Bosa,1, Patricia Fernández-Garcíab, Cristina de Manuelc, Ana Morales-Tiradod, Alejandro López-Neyrab, Marta Ruiz de Valbuenac, Margarita Rubioe, Verónica Sanz-Santiagob,
Corresponding author
a ImFINE Research Group, Health and Human Performance Department, Faculty of Physical Activity and Sport Sciences, Universidad Politécnica de Madrid, Madrid, Spain
b Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital Infantil Universitario Infantil Niño Jesús, Madrid, Spain
c Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital Universitario La Paz, Madrid, Spain
d Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital Infantil Universitario Ramón y Cajal, Madrid, Spain
e Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain